NFKB1 and Parkinson disease: As described above, the interaction of α-syn with microglia causes activation of NF-kB, which is central to a broad range of neuroinflammatory processes (Tobon-Velasco et al., 2014); therefore, inhibition of this signaling pathway could be a therapeutic target for PD.